logologo
Search or Ask Iris
Ctrl+K
arrow
ToolBar Logo
MBEQU2249

IOL Chemicals & Pharmaceuticals Ltd

IOLCP

Watchlist
AI Mode

AI Mode



Market Cap

₹ 2,422 Cr

P/E

20.89


Investment Checklist



























Overview

Detailed Summary
Overview StarOverview StarOverview Star

IOL Chemicals and Pharmaceuticals Limited (IOLCP) operates within the API and specialty chemicals sectors, offering a diverse range of products for pharmaceuticals and broader industrial applications.

Overview StarOverview StarOverview Star

IOLCP has recently secured EDQM certification for Pantoprazole Sodium Sesquihydrate Process-III, bolstering its export capabilities to Europe which points to strengthening its global market reach.

Overview StarOverview StarOverview Star

Revenue for H1 FY26 stood at INR 1,119.2 crore, reflecting an 8.9% year-on-year growth, supported by strategic expansions and the ramp-up in non-Ibuprofen APIs.

Overview StarOverview StarOverview Star

The company is leveraging backward integration for margins and supply chain resilience, while continuing to expand non-Ibuprofen business to diversify its product range and drive future revenue growth.

Overview StarOverview StarOverview Star

Facing higher fuel costs due to the Punjab floods, IOLCP managed to sustain its profitability by focusing on operational efficiency and strategic capex toward automation.

Sector

Pharmaceuticals

Industry

Pharmaceuticals - Indian - Bulk Drugs & Formln M/S

Market Cap

2,422 Cr

Volatility

High Risk

P/E Ratio

20.9

Industry P/E

30.8

PEG Ratio

1.0

P/B Ratio

1.4

52W High

126.60

52W Low

57.51

Sales CAGR

1Y

-2.51%

3Y

-1.63%

5Y

1.88%

10Y

13.90%

Profit CAGR

1Y

-24.82%

3Y

-15.21%

5Y

-22.50%

10Y

ROE

TTM

6.62%

3Y

7.83%

5Y

13.23%

10Y

16.90%

ROCE

TTM

9.15%

3Y

11.10%

5Y

17.54%

10Y

23.03%

Technicals

Oscillators

BearishNeutralBullish

Neutral

Bearish

2

Neutral

8

Bullish

4

Overall

BearishNeutralBullish

Bearish

Bearish

29

Neutral

8

Bullish

9

Moving Averages

BearishNeutralBullish

Bearish

Bearish

27

Neutral

0

Bullish

5

Overall

BearishNeutralBullish

Bearish

Bearish

29

Neutral

8

Bullish

9

Forecasts

No. of Analysts

10

No. of Analysts

1Y Price Target

112.20 ▲ 36.91%

1Y Price Target

Q3 EPS Estimate

Q3 EPS Estimate

Q3 Revenue Estimate

Q3 Revenue Estimate

Unlock Premium Features

Price, EPS and Revenue Projections

forecasts-premiumforecasts-premium
Strong SellSellHoldBuyStrong Buy

Strong Buy

Strong Buy

5

Buy

4

Hold

1

Sell

0

Strong Sell

0

updated on

Dec 03, 2025

Shareholdings

Shareholding History

Quarterly
Yearly
Quarterly
Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025
Promoters43.69%48.19%48.19%48.19%48.19%48.19%48.19%48.19%52.62%52.62%52.62%52.62%
FIIs2.37%2.43%3.54%2.34%2.18%1.41%1.39%1.63%1.49%1.47%2.59%2.25%
DIIs0.17%0.24%0.26%0.36%0.37%0.30%0.10%0.08%0.08%0.07%0.02%0.04%
Public53.77%49.13%48.01%49.11%49.26%50.10%50.32%50.10%45.81%45.83%44.76%45.09%
Total Shareholders1,43,3271,40,1771,26,0041,35,3971,34,2351,30,0031,28,6891,25,9791,26,7011,30,0021,25,0401,36,129

Market Transactions

DatePartyCategoryTypeAvg Price (₹)Total Value (₹)QuantityPercent Traded
Sep 09, 2025Qe securities llpBulkBuy117.5223.28 Cr19,81,0220.67
Sep 09, 2025Hrti private limitedBulkBuy117.6021.22 Cr18,04,6270.61
Sep 09, 2025Hrti private limitedBulkSell117.8023.68 Cr20,10,0690.68
Sep 09, 2025Qe securities llpBulkSell117.4724.36 Cr20,73,7420.70
Sep 12, 2024Hrti private limitedBulkBuy508.7924.71 Cr4,85,7270.16
Sep 12, 2024Qe securities llpBulkBuy507.7114.71 Cr2,89,6450.09
Sep 12, 2024Qe securities llpBulkSell507.5816.20 Cr3,19,0690.10
Sep 12, 2024Hrti private limitedBulkSell507.5322.92 Cr4,51,5320.15
Mar 19, 2024Qe securities llpBulkBuy402.3115.26 Cr3,79,1890.12
Mar 19, 2024Qe securities llpBulkSell402.6015.77 Cr3,91,6090.13

Projection

Pro

Unlock Premium Features

Get In-depth insights on EPS and Revenue forecasts

eps-premiumeps-premiumeps-premiumeps-premium
starsstars

Actions

Action Type




























































Documents

Presentations
Concalls
Reports
Presentations
iconiconicon

Investor Presentation

Q2 FY26

iconiconicon

Investor Presentation

Q1 FY26

iconiconicon

Investor Presentation

Q4 FY25

iconiconicon

Investor Presentation

Q3 FY25

iconiconicon

Investor Presentation

Q2 FY25

iconiconicon

Investor Presentation

Q4 FY24

iconiconicon

Investor Presentation

Q3 FY24

iconiconicon

Investor Presentation

Q2 FY24

Showing 1 - 8 of 22

AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.

AI Mode

AI Mode

ai-corner-premiumai-corner-premium
ai-corner-premiumai-corner-premium